The present invention relates to novel active compound combinations comprising at least one known compound of the formula (I) ##STR00001##
in which X, R.sub.1 to R.sub.4, A, n, Y, and m are as defined in the description, and at least one further known active compound from the class of avermectins/milbemycins, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.

The present invention relates to novel active compound combinations comprising at least one known compound of the formula (I) ##STR00001##
in which X, R.sub.1 to R.sub.4, A, n, Y, and m are as defined in the description, and at least one further known active compound from the class of avermectins/milbemycins, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.

The present invention relates to novel active compound combinations comprising at least one known compound of the formula (I) ##STR00001## in which X, R.sub.1 to R.sub.4, A, n, Y, and m are as defined in the description, and at least one further known active compound from the class of the fiproles, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.

The present invention relates to novel active compound combinations comprising at least one known compound of the formula (I) ##STR00001## in which X, R.sub.1 to R.sub.4, A, n, Y, and m are as defined in the description, and at least one further known active compound from the class of the fiproles, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.

The present invention relates to novel active compound combinations comprising at least one known compound of the formula (I) ##STR00001## in which X, R.sub.1 to R.sub.4, A, n, Y, and m are as defined in the description, and at least one further known active compound from the class of the fiproles, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.

Disclosed are methods of preparing an antimicrobial cross-linked polymeric poly carboxylic acid with improved in-use stability and service life, by making a cross-linked polymeric polycarboxylic acid containing ammonium groups. Also disclosed are the antimicrobial cross-linked polymeric polycarboxylic acids made by the methods, antimicrobial water-absorbent cross-linked polymeric poly carboxylic acids made by the methods, and water-absorbent materials comprising the antimicrobial cross-linked polymeric poly carboxylic acids.

Disclosed are methods of preparing an antimicrobial cross-linked polymeric poly carboxylic acid with improved in-use stability and service life, by making a cross-linked polymeric polycarboxylic acid containing ammonium groups. Also disclosed are the antimicrobial cross-linked polymeric polycarboxylic acids made by the methods, antimicrobial water-absorbent cross-linked polymeric poly carboxylic acids made by the methods, and water-absorbent materials comprising the antimicrobial cross-linked polymeric poly carboxylic acids.

A portable mosquito-control volatilization apparatus, including a box body having an opening, an adsorption structure arranged inside the box body and configured to adsorb a repellent, and a protective-cover structure detachably assembled at the opening to cover the adsorption structure and configured to leak or cover a volatile gas generated by the repellent. After the box body is arranged with the adsorption structure that adsorbs the repellent, the volatilization of the repellent can be achieved. At the same time, the protective-cover structure can cover the adsorption structure to prevent the adsorption structure from detaching from the box body, without the need to paint the repellent on the skin, effectively avoiding a contact between the repellent and the user's skin, thereby avoiding the sticky discomfort, safety hazard, and quick volatilization leading to waste all caused by the direct contact between the repellent and the skin.

A portable mosquito-control volatilization apparatus, including a box body having an opening, an adsorption structure arranged inside the box body and configured to adsorb a repellent, and a protective-cover structure detachably assembled at the opening to cover the adsorption structure and configured to leak or cover a volatile gas generated by the repellent. After the box body is arranged with the adsorption structure that adsorbs the repellent, the volatilization of the repellent can be achieved. At the same time, the protective-cover structure can cover the adsorption structure to prevent the adsorption structure from detaching from the box body, without the need to paint the repellent on the skin, effectively avoiding a contact between the repellent and the user's skin, thereby avoiding the sticky discomfort, safety hazard, and quick volatilization leading to waste all caused by the direct contact between the repellent and the skin.

The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof.